Cargando…

New Cardiotoxicity Risk Assessment Guidelines: Searching for Validation

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Rashed, Eman R., Margulies, Kenneth B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635886/ https://www.ncbi.nlm.nih.gov/pubmed/37969648 http://dx.doi.org/10.1016/j.jaccao.2023.06.006

Ejemplares similares

How to Apply Translational Models to Probe Mechanisms of Cardiotoxicity
por: Livingston, Carissa E., et al.
Publicado: (2022)

3158 Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
por: Livingston, Carissa, et al.
Publicado: (2019)

Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
por: Truitt, Rachel, et al.
Publicado: (2018)

A New Strategy for the Rapid Identification and Validation of the Direct Targets of Aconitine-Induced Cardiotoxicity
por: Wei, Jinxia, et al.
Publicado: (2021)

The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity
por: Di Lisi, Daniela, et al.
Publicado: (2022)

Validation of TIRADS ACR Risk Assessment of Thyroid Nodules in Comparison to the ATA Guidelines
por: Merhav, Goni, et al.
Publicado: (2021)

Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment
por: Clark, Robyn A., et al.
Publicado: (2017)

Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations
por: Corrias, A., et al.
Publicado: (2010)

Assessment and Management of Cardiotoxicity in Hematologic Malignancies
por: Bojan, Anca, et al.
Publicado: (2021)

Assessing Silent Cardiotoxicity in Long-Term Lymphoma Survivors Treated With Radiotherapy
por: Miller, Eric, et al.
Publicado: (2021)

Cardiotoxicity risk factors with immune checkpoint inhibitors
por: Brumberger, Zachary L., et al.
Publicado: (2022)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Cardiotoxicity assessment in breast cancer patients: is it straining?( )
por: Villarraga, Hector, et al.
Publicado: (2022)

Comparison of Patients’ Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs
por: Piña, Pamela, et al.
Publicado: (2022)

Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!
por: El-Rayes, Malak, et al.
Publicado: (2023)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
por: Chang, Wei‐Ting, et al.
Publicado: (2021)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
por: Macedo, Ariane V.S., et al.
Publicado: (2019)

Analysis and Validation of Differentially Expressed Ferroptosis-Related Genes in Regorafenib-Induced Cardiotoxicity
por: Zhang, Siyuan, et al.
Publicado: (2022)

Examining Cardiotoxicity With HER2 Therapies
por: Denduluri, Neelima
Publicado: (2020)

5-Fluorouracil Cardiotoxicity: Known But Unknown
por: Brell, Joanna M.
Publicado: (2021)

Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
por: Samir, Rania, et al.
Publicado: (2023)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
por: Yu, Anthony F., et al.
Publicado: (2020)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

Assessment of late cardiotoxic effects in patients treated for cancer in childhood
por: Kincl, Vladimír, et al.
Publicado: (2022)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
por: Jiang, Jin, et al.
Publicado: (2022)

Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor‐associated cardiotoxicity
por: Liang, Lin, et al.
Publicado: (2023)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Conversion of a colorectal cancer guideline into clinical decision trees with assessment of validity
por: Keikes, Lotte, et al.
Publicado: (2021)

Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2020)

Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime
por: Racioppi, María Florencia, et al.
Publicado: (2021)

Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer
por: Wang, Dennis D., et al.
Publicado: (2021)

Anthracycline-Induced Cardiotoxicity: Remembering the Forgotten Ventricle
por: Liu, Jennifer E.
Publicado: (2020)

Expert validation of fit-for-purpose guidelines for designing programmes of assessment
por: Dijkstra, Joost, et al.
Publicado: (2012)

Carcinogen risk assessment guidelines and children.
por: Buffler, P A, et al.
Publicado: (1999)

Ageing is a risk factor in imatinib mesylate cardiotoxicity
por: Maharsy, Wael, et al.
Publicado: (2014)

Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy
por: Jones, K. A., et al.
Publicado: (2020)

Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7b7ihnbpfkv1er44onbpv8voip